Statistical consideration when adding new arms to ongoing clinical trials: the potentials and the caveats. (2021)
Attributed to:
Developing efficient perpetual platform trials to study multiple treatments and multiple biomarkers
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.69884
Publication URI: https://www.repository.cam.ac.uk/handle/1810/322426
Type: Journal Article/Review